• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼黑素瘤的遗传学:遗传学、遗传与检测的新视角。

Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.

机构信息

Department of Ophthalmology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.

Department of Clinical Genetics, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.

出版信息

Int J Mol Sci. 2020 Dec 30;22(1):336. doi: 10.3390/ijms22010336.

DOI:10.3390/ijms22010336
PMID:33396957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7795687/
Abstract

Ocular melanoma consists of posterior uveal melanoma, iris melanoma and conjunctival melanoma. These malignancies derive from melanocytes in the uveal tract or conjunctiva. The genetic profiles of these different entities differ from each other. In uveal melanoma, and gene mutations are frequently found and prognosis is based on mutation status of , and genes. Iris melanoma, also originating from the uvea, has similarities to the genetic makeups of both posterior uveal melanoma (UM) and conjunctival melanoma since mutations in and are less common and genes involved in conjunctival melanoma such as have been described. The genetic spectrum of conjunctival melanoma, however, includes frequent mutations in the , and promoter genes, which are found in cutaneous melanoma as well. The status of the tumor is not correlated to prognosis, whereas the promoter gene mutations are. Clinical presentation, histopathological characteristics and copy number alterations are associated with survival in ocular melanoma. Tissue material is needed to classify ocular melanoma in the different subgroups, which creates a need for the use of noninvasive techniques to prognosticate patients who underwent eye preserving treatment.

摘要

眼黑色素瘤包括脉络膜黑色素瘤、虹膜黑色素瘤和结膜黑色素瘤。这些恶性肿瘤来源于葡萄膜或结膜的黑色素细胞。这些不同实体的遗传特征彼此不同。在脉络膜黑色素瘤中,经常发现 和 基因突变,预后基于 、 和 基因突变状态。起源于葡萄膜的虹膜黑色素瘤与脉络膜黑色素瘤(UM)和结膜黑色素瘤的遗传构成相似,因为 和 基因突变较少见,而结膜黑色素瘤中涉及的基因,如 ,已有描述。然而,结膜黑色素瘤的遗传谱包括 在 、 和 启动子基因中的频繁突变,这些突变也存在于皮肤黑色素瘤中。肿瘤的 状态与预后无关,而 启动子基因突变与预后相关。临床表型、组织病理学特征和拷贝数改变与眼黑色素瘤的生存相关。为了对不同亚组的眼黑色素瘤进行分类,需要组织材料,这就需要使用非侵入性技术来预测接受保眼治疗的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/d146c167d05e/ijms-22-00336-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/db132463e59b/ijms-22-00336-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/c51604a5e066/ijms-22-00336-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/de83e54d57bc/ijms-22-00336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/a73d17f01453/ijms-22-00336-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/906762fd030f/ijms-22-00336-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/d146c167d05e/ijms-22-00336-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/db132463e59b/ijms-22-00336-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/c51604a5e066/ijms-22-00336-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/de83e54d57bc/ijms-22-00336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/a73d17f01453/ijms-22-00336-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/906762fd030f/ijms-22-00336-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6b/7795687/d146c167d05e/ijms-22-00336-g006.jpg

相似文献

1
Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.眼黑素瘤的遗传学:遗传学、遗传与检测的新视角。
Int J Mol Sci. 2020 Dec 30;22(1):336. doi: 10.3390/ijms22010336.
2
Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.葡萄膜黑色素瘤中的驱动基因突变:与基因表达谱和患者预后的关联。
JAMA Ophthalmol. 2016 Jul 1;134(7):728-33. doi: 10.1001/jamaophthalmol.2016.0903.
3
Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.葡萄膜黑色素瘤中 GNAQ、GNA11、BAP1、SF3B1、EIF1AX 和 TERT 的突变频率:在单个葡萄膜黑色素瘤病例中检测到 TERT 基因启动子的激活突变。
Br J Cancer. 2014 Feb 18;110(4):1058-65. doi: 10.1038/bjc.2013.804. Epub 2014 Jan 14.
4
Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.GNAQ、GNA11、BAP1、SF3B1、SRSF2、EIF1AX、PLCB4 和 CYSLTR2 基因的生物信息学分析及其在葡萄膜黑色素瘤发病机制中的作用。
Ophthalmic Genet. 2021 Dec;42(6):732-743. doi: 10.1080/13816810.2021.1961280. Epub 2021 Aug 6.
5
Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.虹膜黑色素瘤和虹膜黑色素细胞瘤的遗传背景。
Ophthalmology. 2018 Jun;125(6):904-912. doi: 10.1016/j.ophtha.2017.12.022. Epub 2018 Jan 19.
6
Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients.中国人群葡萄膜黑色素瘤中的 GNAQ、GNA11、SF3B1、EIF1AX、PLCB4 和 CYSLTR 基因突变。
Ophthalmic Res. 2020;63(3):358-368. doi: 10.1159/000502888. Epub 2019 Oct 15.
7
Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.虹膜黑色素瘤中常见的GNAQ、GNA11和EIF1AX突变
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3464-3470. doi: 10.1167/iovs.17-21838.
8
Genetic and clinico-pathologic analysis of metastatic uveal melanoma.葡萄膜黑色素瘤转移的遗传及临床病理分析。
Mod Pathol. 2014 Feb;27(2):175-83. doi: 10.1038/modpathol.2013.138. Epub 2013 Jul 26.
9
Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.染色体 3 状态联合 BAP1 和 EIF1AX 突变谱与葡萄膜黑色素瘤的转移相关。
Invest Ophthalmol Vis Sci. 2014 Jun 26;55(8):5160-7. doi: 10.1167/iovs.14-14550.
10
Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.葡萄膜黑色素瘤中染色体畸变以及GNAQ、GNA11和BAP1突变的预后影响
Acta Ophthalmol. 2018 Feb;96(1):31-38. doi: 10.1111/aos.13452. Epub 2017 Apr 26.

引用本文的文献

1
Conjunctival melanoma: comprehensive insights into clinical features, genetic alterations, and modern treatment approaches.结膜黑色素瘤:对临床特征、基因改变及现代治疗方法的全面见解
Pathol Oncol Res. 2025 Aug 4;31:1612085. doi: 10.3389/pore.2025.1612085. eCollection 2025.
2
Advances and Challenges in Immunotherapy for Metastatic Uveal Melanoma: Clinical Strategies and Emerging Targets.转移性葡萄膜黑色素瘤免疫治疗的进展与挑战:临床策略与新兴靶点
J Clin Med. 2025 Jul 19;14(14):5137. doi: 10.3390/jcm14145137.
3
Cutaneous melanoma.皮肤黑色素瘤

本文引用的文献

1
Prognostic value of promoter mutations in conjunctival melanomas in addition to clinicopathological features.除临床病理特征外,结膜黑色素瘤启动子突变的预后价值。
Br J Ophthalmol. 2021 Oct;105(10):1454-1461. doi: 10.1136/bjophthalmol-2020-317405. Epub 2020 Oct 30.
2
Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma.循环肿瘤细胞和循环肿瘤DNA在葡萄膜黑色素瘤中的临床应用
JCO Precis Oncol. 2018 May 17;2. doi: 10.1200/PO.17.00279. eCollection 2018.
3
Conjunctival Melanoma in Childhood and Adolescence: A Systematic Review.
Nat Rev Dis Primers. 2025 Apr 3;11(1):23. doi: 10.1038/s41572-025-00603-8.
4
Development of a prognostic nomogram for ocular melanoma: a SEER population-based study (2000-2021).眼部黑色素瘤预后列线图的开发:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究(2000 - 2021年)
Front Med (Lausanne). 2025 Jan 29;12:1494925. doi: 10.3389/fmed.2025.1494925. eCollection 2025.
5
The roles of genetic mutation and cytokines/chemokines in immune response and their association with uveal melanoma patient outcome.基因突变和细胞因子/趋化因子在免疫反应中的作用及其与葡萄膜黑色素瘤患者预后的关联。
Heliyon. 2024 Sep 11;10(18):e37852. doi: 10.1016/j.heliyon.2024.e37852. eCollection 2024 Sep 30.
6
Uveal Melanoma: Comprehensive Review of Its Pathophysiology, Diagnosis, Treatment, and Future Perspectives.葡萄膜黑色素瘤:其病理生理学、诊断、治疗及未来展望的综合综述
Biomedicines. 2024 Aug 5;12(8):1758. doi: 10.3390/biomedicines12081758.
7
Biological characteristics and clinical management of uveal and conjunctival melanoma.葡萄膜和结膜黑色素瘤的生物学特性及临床处理。
Oncol Res. 2024 Jul 17;32(8):1265-1285. doi: 10.32604/or.2024.048437. eCollection 2024.
8
Genetic Risk Factors and Clinical Outcomes in Childhood Eye Cancers: A Review.儿童眼部肿瘤的遗传风险因素与临床结局:综述
Genes (Basel). 2024 Feb 22;15(3):276. doi: 10.3390/genes15030276.
9
Genetic analysis of ocular tumour-associated genes using large genomic datasets: insights into selection constraints and variant representation in the population.利用大型基因组数据集进行眼部肿瘤相关基因的遗传分析:人群中选择约束和变异体表达的见解。
BMJ Open Ophthalmol. 2024 Feb 21;9(1):e001565. doi: 10.1136/bmjophth-2023-001565.
10
N6-methyladenosine methylation in ophthalmic diseases: From mechanisms to potential applications.眼科疾病中的N6-甲基腺苷甲基化:从机制到潜在应用
Heliyon. 2023 Dec 13;10(1):e23668. doi: 10.1016/j.heliyon.2023.e23668. eCollection 2024 Jan 15.
儿童及青少年结膜黑色素瘤:一项系统综述
Ocul Oncol Pathol. 2019 Oct;5(6):387-395. doi: 10.1159/000497813. Epub 2019 Apr 10.
4
Uveal melanoma-associated survival in Scotland.苏格兰葡萄膜黑色素瘤相关生存率
Eye (Lond). 2019 Nov;33(11):1699-1706. doi: 10.1038/s41433-019-0622-9. Epub 2019 Oct 25.
5
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201).卡博替尼对比化疗用于转移性葡萄膜黑色素瘤的随机 II 期临床试验和肿瘤突变频谱分析(Alliance A091201)。
Clin Cancer Res. 2020 Feb 15;26(4):804-811. doi: 10.1158/1078-0432.CCR-19-1223. Epub 2019 Sep 26.
6
Mutations in Uveal Melanoma: A Preference for In-Frame Deletions?葡萄膜黑色素瘤中的突变:对框内缺失有偏好吗?
Cancers (Basel). 2019 Aug 17;11(8):1200. doi: 10.3390/cancers11081200.
7
Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.肿瘤厚度较大、溃疡形成和前哨淋巴结阳性与结膜黑色素瘤患者的预后不良相关:对未来 AJCC 分类的影响。
Am J Surg Pathol. 2019 Dec;43(12):1701-1710. doi: 10.1097/PAS.0000000000001344.
8
Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines.荷兰的BAP1肿瘤易感综合征家庭:识别途径及遗传筛查指南建议
Cancers (Basel). 2019 Aug 4;11(8):1114. doi: 10.3390/cancers11081114.
9
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma.早期和转移性葡萄膜黑色素瘤循环肿瘤细胞的初步研究
Cancers (Basel). 2019 Jun 20;11(6):856. doi: 10.3390/cancers11060856.
10
Pembrolizumab as first-line treatment for metastatic uveal melanoma.派姆单抗作为一线治疗转移性葡萄膜黑色素瘤的药物。
Cancer Immunol Immunother. 2019 Jul;68(7):1179-1185. doi: 10.1007/s00262-019-02352-6. Epub 2019 Jun 7.